Minireviews
Copyright ©The Author(s) 2023.
World J Gastroenterol. Mar 14, 2023; 29(10): 1551-1568
Published online Mar 14, 2023. doi: 10.3748/wjg.v29.i10.1551
Figure 1
Figure 1 First-line systemic therapy in unresectable hepatocellular carcinoma. ECOG PS: Eastern Cooperative Oncology Group Performance Status; ICIs: Immune checkpoint inhibitors; HCC: Hepatocellular carcinoma.
Figure 2
Figure 2 Second-line systemic therapy in unresectable hepatocellular carcinoma. DP: Disease progress; ECOG PS: Eastern Cooperative Oncology Group Performance Status; ICIs: Immune checkpoint inhibitors; HCC: Hepatocellular carcinoma; AFP: Alpha-fetoprotein.